Results for tag: "Trelstar"

Trelstar is a market of prostate cancer drugs developed by Endo Pharmaceuticals. It is a long-acting gonadotropin-releasing hormone (GnRH) agonist, which works by reducing the production of testosterone, a hormone that can stimulate the growth of prostate cancer cells. Trelstar is administered as an injection every three months, and is used to treat advanced prostate cancer in men. It is also used to treat precocious puberty in children. Trelstar is a part of the larger prostate cancer drug market, which includes other GnRH agonists, anti-androgens, and chemotherapy drugs. These drugs are used to treat prostate cancer in different stages, from early to advanced. The market is highly competitive, with many companies offering different treatments. Some companies in the Trelstar market include Endo Pharmaceuticals, AbbVie, Astellas Pharma, and Pfizer. Show Less Read more